Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
  1. 4 Planned sale Henn Matthew R. sold 927 shares at $0.54 ($501)
  2. 4 Planned sale von Moltke Lisa sold 4,334 shares at $0.69 ($2,991)
  3. 4 Planned sale Henn Matthew R. sold 3,984 shares at $0.69 ($2,749)
  4. 4 Planned sale Chief Legal Officer and EVP sold 4,259 shares at $0.69 ($2,939)
  5. 4 Planned sale CEO and President sold 8,748 shares at $0.69 ($6,037)
  6. 4 Planned sale Young Teresa L. sold 2,983 shares at $0.69 ($2,059)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Planned sale Chief Legal Officer and EVP sold 873 shares at $0.84 ($733)
  9. 4 Planned sale von Moltke Lisa sold 973 shares at $0.84 ($817)
  10. 4 Planned sale Henn Matthew R. sold 923 shares at $0.84 ($775)
  11. 4 Planned sale CEO and President sold 2,518 shares at $0.84 ($2,115)
  12. 4 Planned sale Young Teresa L. sold 728 shares at $0.84 ($612)
  13. 4 Planned sale Ege David S. sold 1,128 shares at $0.84 ($948)
  14. 4 Planned sale Young Teresa L. sold 24,480 shares at $1.08 ($26,534)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale von Moltke Lisa sold 939 shares at $0.94 ($883)
  19. 4 Planned sale CEO and President sold 2,435 shares at $0.94 ($2,289)
  20. 4 Planned sale Young Teresa L. sold 703 shares at $0.94 ($661)

Page 5 of 19 · 380 filings